These are robust, clinically meaningful differences that survived propensity score matching to control for confounding variables like age, BMI, comorbidities, and medication history
The dosing structures are different, the concentrations from compounding pharmacies are different, and the clinical outcomes are different
Both compounds produce large body-weight reductions in obesity trials, and both are once-weekly subcutaneous injections dominated by gastrointestinal side effects
So far, the evidence suggests that its safe for people with UC to take Ozempic and other similar medications
Retatrutide Highest efficacy (~24%) but higher side effect rates
And this is the one thing even above weight loss surgery that has helped me a lot and cured me and mentally made me so much better